Solid Tumors
A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)
- Details
ClinicalTrials.gov ID:
NCT04083976
Diagnosis Type:
NA
USOR Number:
- Address
1200 Brooklyn Ave, Suite 115
San
Antonio, TX 78212
P: (210) 224-6531